Zilong Wang

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Epithelial Mesenchymal Transition

Bioinformatics Analysis

Top Venues

OncoTargets and therapy

Oxidative medicine and cellular longevity

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang, Xunbo Jin
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis. Oxidative medicine and cellular longevity 2021 (2021)
Chenglin Han, Shuxiao Chen, Haiyang Ma, Xiangchuan Wen, Zilong Wang, Yingkun Xu, Xunbo Jin, Xiao Yu, Muwen Wang
RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway. OncoTargets and therapy 14 (2021)
Guangzhen Wu, Yingkun Xu, Chenglin Han, Zilong Wang, Jiayi Li, Qifei Wang, Xiangyu Che
Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration. Journal of oncology 2020 (2020)